Evidence Hub

Malaria in Mvumi, central Tanzania and the in vivo response of Plasmodium falciparum to chloroquine and sulphadoxine pyrimethamine

Wakibara JV, Mboera LE, Ndawi BT

East African medical journal, 1997

Abstract

A study on the prevalence of malaria and the response of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine was conducted in Mvumi area of central Tanzania. Splenomegaly was observed at a rate of 62% and 36% in children and adults respectively. Crude malaria parasite rate was 55.4% in children and 32% in adults. Plasmodium falciparum accounted for the highest proportion (62.7%) of the malaria parasites in the area. This malaria parasite was sensitive to standard dosage of either chloroquine or sulphadoxine-pyrimethamine. Sulphadoxine-pyrimethamine cleared the parasites to undetectable levels by day seven of administration whereas chloroquine cleared parasitaemia in 91% of the subjects by the seventh day. Despite the virtual absence of adult Anopheles mosquitoes during the study period, a larval survey indicated that breeding of Anopheles gambiae s.l. was taking place in nearby irrigation streams. Culex quinquefasciatus was the dominant man-biting mosquito in the area.

How strong is the evidence?

Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free